The ProLung Test™
The only predictive analytics technology available for the lung*
The ProLung Test is an innovative predictive analytics technology and non-invasive test for the risk stratification of indeterminate pulmonary nodules that can lead to lung cancer. It uses precision proprietary volume-averaging bioconductance technology to measure the difference in conductivity between malignant and benign lung tissue. The patient’s test results are analyzed to produce a personalized and predictive score indicating the likelihood that a particular lesion in the lungs is malignant.